W.B.D.
MONEY

Novo Nordisk Wipes Out $30 Billion In Market Value After Failed Heart Drug Trial

By W.B.D. Editorial
Novo Nordisk Wipes Out $30 Billion In Market Value After Failed Heart Drug Trial

Analysts were critical of the Ozempic maker’s failed trial for a new experimental drug.

Read the full story at Forbes →